These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. Turner AK, Nair S, Wain J. J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934 [Abstract] [Full Text] [Related]
4. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC. Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915 [Abstract] [Full Text] [Related]
5. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Akasaka T, Tanaka M, Yamaguchi A, Sato K. Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683 [Abstract] [Full Text] [Related]
6. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates]. Guo Y, Pei X, Liu X. Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489 [Abstract] [Full Text] [Related]
7. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken. Lee YJ, Cho JK, Kim KS, Tak RB, Kim AR, Kim JW, Im SK, Kim BH. J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029 [Abstract] [Full Text] [Related]
8. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran. Nouri R, Ahangarzadeh Rezaee M, Hasani A, Aghazadeh M, Asgharzadeh M. Braz J Microbiol; 2016 Oct; 47(4):925-930. PubMed ID: 27522930 [Abstract] [Full Text] [Related]
9. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Rubin J, Walker RD, Blickenstaff K, Bodeis-Jones S, Zhao S. Vet Microbiol; 2008 Sep 18; 131(1-2):164-72. PubMed ID: 18395369 [Abstract] [Full Text] [Related]
10. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi. Agrawal P, Kapila K, Kumar S, Ghosh AN, Maurya AK. Indian J Pathol Microbiol; 2010 Sep 18; 53(3):509-12. PubMed ID: 20699513 [Abstract] [Full Text] [Related]
12. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Pasquali F, Manfreda G. Vet Microbiol; 2007 Jan 31; 119(2-4):304-10. PubMed ID: 16987619 [Abstract] [Full Text] [Related]
14. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Shultz TR, Tapsall JW, White PA. Antimicrob Agents Chemother; 2001 Mar 31; 45(3):734-8. PubMed ID: 11181352 [Abstract] [Full Text] [Related]
15. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S. J Antimicrob Chemother; 2006 Dec 31; 58(6):1139-44. PubMed ID: 17071955 [Abstract] [Full Text] [Related]
16. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan. Chiu CH, Lee HY, Tseng LY, Chen CL, Chia JH, Su LH, Liu SY. Int J Antimicrob Agents; 2010 Apr 31; 35(4):382-6. PubMed ID: 20138741 [Abstract] [Full Text] [Related]
17. [A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone]. Lei Y, Gui X, Feng G. Zhonghua Nei Ke Za Zhi; 2001 Mar 31; 40(3):176-9. PubMed ID: 11798575 [Abstract] [Full Text] [Related]
18. Real-time PCR detection of Pseudomonas aeruginosa in clinical and municipal wastewater and genotyping of the ciprofloxacin-resistant isolates. Schwartz T, Volkmann H, Kirchen S, Kohnen W, Schön-Hölz K, Jansen B, Obst U. FEMS Microbiol Ecol; 2006 Jul 31; 57(1):158-67. PubMed ID: 16819959 [Abstract] [Full Text] [Related]
19. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography. Matsumoto M, Shigemura K, Shirakawa T, Nakano Y, Miyake H, Tanaka K, Kinoshita S, Arakawa S, Kawabata M, Fujisawa M. Int J Antimicrob Agents; 2012 Nov 31; 40(5):440-4. PubMed ID: 22884856 [Abstract] [Full Text] [Related]
20. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait. Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. J Clin Pathol; 2010 Jan 31; 63(1):83-7. PubMed ID: 19889623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]